Lumirelax
Lumirelax Brand names, Lumirelax Analogs
- AHR 85
- Avetil
- Delaxin
- Etroflex
- Forbaxin
- Glycerylguaiacolate carbamate
- Glycerylguajacol-Carbamat
- Guaiacol glyceryl ether carbamate
- Guaiphenesin carbamate
- Guaiphenesine carbamate
- Lumirelax
- Methocal
- Metocarbamol
- Metocarbamolo
- Metofenia
- Metofenina
- Miolaxene
- Miorilas
- Miowas
- Myolaxene
- Neuraxin
- Parabaxin
- Perilax
- Reflexyn
- Relax
- Relestrid
- Robamol
- Robaxan
- Robaxin
- Robaxine
- Robaxon
- Robinax
- Romethocarb
- Surquetil
- Traumacut
- Tresortil
Lumirelax Brand Names Mixture
- No information avaliable
Lumirelax Chemical_Formula
C14H14N2O
Lumirelax RX_link
http://www.rxlist.com/cgi/generic3/metopirone.htm
Lumirelax fda sheet
Lumirelax msds (material safety sheet)
Lumirelax Synthesis Reference
No information avaliable
Lumirelax Molecular Weight
226.274 g/mol
Lumirelax Melting Point
50.5 oC
Lumirelax H2O Solubility
Sparingly soluble
Lumirelax State
Solid
Lumirelax LogP
2.303
Lumirelax Dosage Forms
Capsules for oral administration (250 mg)
Lumirelax Indication
Used as a diagnostic drug for testing hypothalamic-pituitary ACTH function.
Lumirelax Pharmacology
Metopirone is an inhibitor of endogenous adrenal corticosteroid synthesis.
Lumirelax Absorption
Absorbed rapidly and well when administered orally. Peak plasma concentrations are usually reached 1 hour after administration.
Lumirelax side effects and Toxicity
Oral LD50 in rats is 521 mg/kg. One case has been recorded in which a 6-year-old girl died after two doses of Metopirone, 2 g. Symptoms of overdose include cardiac arrhythmias, hypotension, dehydration, anxiety, confusion, weakness, impairment of consciousness, nausea, vomiting, epigastric pain, and diarrhea.
Lumirelax Patient Information
Lumirelax Organisms Affected
Humans and other mammals
